USepthemba 1 ukuqala kwenyanga ye-lymphoma futhi kusukela namuhla eminye imithi emi-2 emisha yengezwe ku-PBS yeziguli ze-lymphoma.
UNgqongqoshe Wezempilo Wombuso u-Greg Hunt usanda kumemezela ukuthi kusukela mhla lu-1 kuSepthemba, iziguli zase-Australia ezifanele ezine-B cell lymphoma (PMBCL) ebuyele emuva / e-refractory Chronic Lymphocytic Leukemia (CLL) kanye ne-Small Lymphocytic lymphoma (SLL) zizoba nentsha. Izinketho zokwelashwa ezitholakalayo kubo ku-PBS.
I-PMBCL iwuhlobo oluncane lwe-lymphoma oluyivelakancane futhi iziguli manje sezizokwazi ukufinyelela kuyo Keytruda uma bephinde babuyela ekwelashweni kwangaphambilini noma bebengafuni ukwelashwa. I-KEYTRUDA (Pembrolizumab) umuthi we-immunotherapy owenza amasosha omzimba akwazi ukulwa ne-lymphoma.
Ikhono (I-Acalabrutinib) izophinde itholakale ku-PBS ezigulini zase-Australia ezifanele ezine-Chronic Lymphocytic Leukemia kanye ne-Small Lymphocytic Lymphoma. Lezi zinhlobo ze-lymphoma zibhekwa njengomdlavuza ongapheli njengoba ungapheli kodwa i-Calquence inikeza iziguli ezifanelekayo inketho yokwelashwa eyengeziwe.
I-Lymphoma Australia ithanda ukubonga zonke iziguli namanye amalungu omphakathi asizile ngokwenza isicelo ku-PBAC ukuze lezi zindlela zokwelapha ezintsha zigunyazwe kuzo zonke iziguli ezifanele.
Ukuze uthole ulwazi olwengeziwe nokuphawula kwabezindaba, sicela ushayele isikhulu seLymphoma Australia uSharon Winton ku-0431 483 204.
